Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 6Paclitaxel 5Taxes 3Docetaxel 3Cisplatin 3Gemcitabine 2Erlotinib Hydrochloride 2Drug Therapy 2Bevacizumab 2talimogene laherparepvec 1saracatinib 1romidepsin 1rilotumumab 1ganitumab 1Zoledronic Acid 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Therapeutics 1Talc 1Surveys and Questionnaires 1Spectrum Analysis 1Sodium Chloride 1Pemetrexed 1Nivolumab 1Metformin 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Imatinib Mesylate 1Gefitinib 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pleural Effusion, Malignant × Coal Tar × Clear all
NCT02132884 2019-09-04

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Fox Chase Cancer Center

Phase NA Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡